Literature DB >> 15684487

Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits.

Nobuyasu Sekiya1, Mosaburo Kainuma, Hiroaki Hikiami, Takako Nakagawa, Kazufumi Kouta, Naotoshi Shibahara, Yutaka Shimada, Katsutoshi Terasawa.   

Abstract

In this study, we examined whether the Kampo formulas Oren-gedoku-to (OGT, Huanglian-jie-du-tang in Chinese) and Keishi-bukuryo-gan-ryo (KBG, Gui-zhi-fu-ling-wan in Chinese) could prevent the progression of atherosclerosis in cholesterol-fed rabbit, an animal model for hypercholesterolemia in vivo. Twenty-four male Japanese white rabbits (2 kg body weight) were divided into four groups. The control group was fed standard rabbit chow containing 1% cholesterol, the OGT group was fed standard rabbit chow containing 1% cholesterol and 1% OGT, the KBG group was fed standard rabbit chow containing 1% cholesterol and 1% KBG, and the vitamin E group was fed standard rabbit chow containing 1% cholesterol and vitamin E (450 mg/1000 g). All four groups were kept on these diets for 8 weeks. At the end of the experiments, the percentage of surface area of the total thoracic aorta with visible plaque was significantly reduced in the OGT and KBG groups. The serum thiobarbituric acid reactive substances of the vitamin E group showed a significantly low value compared with the control group, whereas the serum lipid peroxide levels of the OGT and KBG groups were considerably lower than that of the control groups as well as that of the vitamin E group. Furthermore, the urinary 8-hydroxydeoxyguanosine levels of the OGT and KBG groups were considerably lower than that of the vitamin E group. These results suggest that OGT and KBG prevent the progression of atheromatous plaque by creating a sounder antioxidant defense system than vitamin E.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684487     DOI: 10.1248/bpb.28.294

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  13 in total

1.  Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.

Authors:  Weibin Qian; Junichi Hasegawa; Satoshi Tsuno; Yusuke Endo; Akiko Matsuda; Norimasa Miura
Journal:  Yonago Acta Med       Date:  2014-12-26       Impact factor: 1.641

2.  Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet.

Authors:  Hong-xia Guo; Dai-hua Liu; Ying Ma; Jin-feng Liu; Ying Wang; Zhi-yan Du; Xin Wang; Jing-kang Shen; Hong-li Peng
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

3.  Neuroprotective effect of Chunghyuldan (Qing Xue Dan) on hypoxia-reoxygenation induced damage of neuroblastoma 2a cell lines.

Authors:  Chang-Nam Ko; In-Seo Park; Seong-Uk Park; Woo-Sang Jung; Sang-Kwan Moon; Jung-Mi Park; Chulhun Kang; Ki-Ho Cho
Journal:  Chin J Integr Med       Date:  2013-12-05       Impact factor: 1.978

4.  Relationship between Blood Stasis Syndrome Score and Cardioankle Vascular Index in Stroke Patients.

Authors:  Ki-Ho Cho; Kyoo-Pil Kim; Byung-Cheol Woo; Young-Jee Kim; Joo-Young Park; Seung-Yeon Cho; Seong-Uk Park; Woo-Sang Jung; Jung-Mi Park; Sang-Kwan Moon
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-31       Impact factor: 2.629

5.  Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design.

Authors:  Yutaka Nagata; Hirozo Goto; Hiroaki Hikiami; Tatsuya Nogami; Makoto Fujimoto; Naotoshi Shibahara; Yutaka Shimada
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-22       Impact factor: 2.629

6.  Effects of Huanglian-Jie-Du-Tang and its modified formula on the modulation of amyloid-β precursor protein processing in Alzheimer's disease models.

Authors:  Siva Sundara Kumar Durairajan; Ying-Yu Huang; Pui-Yee Yuen; Lei-Lei Chen; Ka-Yan Kwok; Liang-Feng Liu; Ju-Xian Song; Quan-Bin Han; Lei Xue; Sookja K Chung; Jian-Dong Huang; Larry Baum; Sanjib Senapati; Min Li
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

7.  Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang.

Authors:  Chang-Seob Seo; Ohn Soon Kim; Jung-Hoon Kim; Hyeun-Kyoo Shin
Journal:  BMC Complement Altern Med       Date:  2015-04-08       Impact factor: 3.659

8.  Evaluation of oxygen radical absorbance capacity in kampo medicine.

Authors:  Ko Nishimura; Toshihiko Osawa; Kenji Watanabe
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-26       Impact factor: 2.629

9.  Transcriptomics Analysis of Candida albicans Treated with Huanglian Jiedu Decoction Using RNA-seq.

Authors:  Qianqian Yang; Lei Gao; Maocan Tao; Zhe Chen; Xiaohong Yang; Yi Cao
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-06       Impact factor: 2.629

10.  Efficacy of Hwangryunhaedok-tang (Huang-lian-jie-du-tang, Oren-gedoku-to) for patients with hyperlipidemia: a study protocol for a randomized, double-blind, placebo-controlled, parallel, investigator-initiated clinical trial.

Authors:  Boram Lee; Kyungsun Han; Hyo-Ju Park; Ae-Ran Kim; O-Jin Kwon; Changsop Yang; Chung-Sik Cho
Journal:  Trials       Date:  2020-08-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.